FDA Approved Medical Products for:

Chronic myeloid leukemia

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Bosutinib
Trade Name
(Manufacturer Name)
Bosulif
(Wyeth Pharmaceuticals, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Treatment of adult patients with chronic, accelerated or blast phase Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) with resistance, or intolerance to prior therapy
More Information about this product Drug Information Portal

Generic Name Imatinib mesylate
Trade Name
(Manufacturer Name)
Gleevec®
(Novartis Pharmaceuticals Corp.)
Indication
The FDA has approved this product to be used in this manner.
Treatment of chronic myelogenous leukemia
More Information about this product Drug Information Portal

Generic Name Ponatinib
Trade Name
(Manufacturer Name)
Iclusig
(ARIAD Pharmaceuticals Inc.)
Indication
The FDA has approved this product to be used in this manner.
Treatment of adult patients with chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML) that is resistant or intolerant to prior tyrosine kinase inhibitor therapy or Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) that is resistant or intolerant to prior tyrosine kinase inhibitor therapy.
More Information about this product Drug Information Portal

Generic Name Interferon alfa-2a (recombinant)
Trade Name
(Manufacturer Name)
Roferon®-A
(Hoffmann-La Roche, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Treatment of chronic myelogenous leukemia.
More Information about this product Drug Information Portal

Generic Name Dasatinib
Trade Name
(Manufacturer Name)
Sprycel®
(Bristol-Myers Squibb Company)
Indication
The FDA has approved this product to be used in this manner.
Treatment of adults with Philadelphia chromosome-positive acute lymphoblastic leukemia with resistance or intolerance to prior therapy
More Information about this product Drug Information Portal

Generic Name Omacetaxine mepesuccinate
Trade Name
(Manufacturer Name)
Synribo
(Teva Pharmaceuticals)
Indication
The FDA has approved this product to be used in this manner.
Treatment of chronic myelogenous leukemia
More Information about this product Drug Information Portal

Generic Name Nilotinib
Trade Name
(Manufacturer Name)
Tasigna®
(Novartis Pharmaceutical Corporation)
Indication
The FDA has approved this product to be used in this manner.
For the use for chronic phase (CP) and accelerated phase (AP) Philadelphia chromosome positive chronic myelogenous leukemia (CML) in adult patients resistant to or intolerant to prior therapy that included Gleevec(imatinib)
More Information about this product Drug Information Portal
Medline Plus Health Information